Navigation Links
Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
Date:11/9/2007

MINNEAPOLIS, Nov. 9 /PRNewswire-USNewswire/ -- This week, Dr. Fouad Bachour, MD, FACC, director of interventional cardiology at Hennepin County Medical Center, presented results of a study at the American Heart Association's Scientific Sessions (http://www.sessionsdailynews.com/tuesday.pdf) meeting in Orlando showing that alerting the hospital as soon as possible before a heart attack patient arrives improves door-to-balloon times -- both during workday hours and after hours. Door-to-balloon time is measured from the time the patient arrives in the emergency department to when the patient's artery is opened and blood flow to the heart is restored in the cardiac catheterization lab.

National studies have shown that during normal workday hours, when cardiac catheterization (cath) labs are fully staffed, the time it takes to open a patient's blocked artery is shorter than after hours when staff has to be called in. Hennepin County Medical Center has reduced the time it takes to get a patient with an acute heart attack to the cath lab for emergency angioplasty by authorizing paramedics to call ahead and alert the cath lab staff directly instead of receiving prior authorization. There's no dispute within the medical community that the quicker the patient receives treatment, the better chance for survival.

"Without blood, cardiac muscle quickly begins to die," explains Dr. Bachour. "The largest gain in time to an open artery can be achieved by concentrating our efforts on management of the pre-hospital phase of patients coming in with a heart attack. Hennepin has been very successful at restoring blood flow to heart tissue and saving lives." Every year an estimated 500,000 Americans experience heart attacks which occur when an artery is completely blocked and blood flow to cardiac muscle is restricted.

According to Dr. Bachour, empowering paramedics to activate the cath lab as soon as they assess the patient at the scene means the cath lab staff are ready and waiting for the patient as soon as he/she arrives at the hospital. Door-to-balloon times using this protocol can be much quicker than the national standard of 90 minutes -- no matter what time of the day.

In 2005, Hennepin paramedics began activating the cardiac cath lab from the field and rigs when they began carrying an electrocardiogram, or EKG, which is used to measure the heart's electrical activity to identify heart attack patients. Since this protocol has been in place, the following door-to-balloon times have been reported:

-- Average door-to-balloon time during regular workday hours decreased

from 73 to 49 minutes

-- Average door-to-balloon time AFTER regular business hours decreased

from 94 to 65 minutes

"We worked very closely with our paramedics and they are directly responsible for the program's success. Using the information we've learned, we hope that more hospitals will see what a difference pre-hospital cath lab activation can make, and that they might consider making similar changes in the way they care for heart attack patients."

Hennepin County Medical Center is a nationally recognized Level 1 Trauma Center with the largest emergency department in Minnesota. The comprehensive academic medical center and public teaching hospital includes a 424-bed acute care hospital and clinics located in downtown Minneapolis and suburban Hennepin County. For the eleventh year in a row, Hennepin is listed in the U.S. News & World Report rankings of the top U.S. Hospitals in its annual "America's Best Hospitals" report. http://www.hcmc.org


'/>"/>
SOURCE Hennepin County Medical Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):